5 Best Dividend Aristocrat Stocks To Buy Now

2. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 84

Johnson & Johnson (NYSE:JNJ) is an American multinational pharmaceutical company that has been raising its dividends consistently for the past 61 years. The company currently offers a quarterly dividend of $1.13 per share for a dividend yield of 2.94%, as of March 20.

Guggenheim initiated its coverage on Johnson & Johnson (NYSE:JNJ) in March with a Neutral rating and a $161 price target, appreciating the company’s MedTech segment. The firm also gave a positive outlook of the company’s other businesses.

Johnson & Johnson (NYSE:JNJ) was a part of 84 hedge fund portfolios in Q4 2022, as per Insider Monkey’s database. The stakes owned by these hedge funds have a total value of over $5.5 billion.

Follow Johnson & Johnson (NYSE:JNJ)